deaths from tirzepatide In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://nej.md/4qd5rLx People Who Stopped Taking the

It plays a critical role in detoxification, immune support, and cellular repair

Dont use specific drugs and supplements: You may be told not to take certain medicines or supplements in the days before your appointment because they could affect blood clotting or the sensitivity of your skin

Pancreatitis and diabetic retinopathy were less common, suggesting semaglutide's benefits in managing type 2 diabetes extend to substantial weight loss and blood pressure improvement, with a need for further safety monitoring

In placebo-controlled trials of patients with type 1 diabetes mellitus, the risk of ketoacidosis was markedly increased in patients who received sodium-glucose cotransporter 2 (SGLT2) inhibitors compared to patients who received placebo